WASHINGTON — Republicans on Capitol Hill are attempting to use a bill to address the opioid crisis to deliver a major victory for the pharmaceutical industry, reversing a measure that put drug makers on the hook for a higher share of Medicare drug costs, according to congressional staff and lobbyists.

The effort could also result in passage of the CREATES Act, legislation that would facilitate the entry of lower-priced generic and biosimilar drugs to the market.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • They are really too corrupt to even consider how their greed and apathy cause this so called epidemic in the first place. Even the number of American deaths, has no impact on their unbridled greed. The addiction crisis should have been addressed by the A.C.A, but these industry puppets, took out key provisions, to undermine our healthcare. They have no shame!

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy